Apr. 29 at 2:32 PM
Missed the Rain Oncology (
$RAIN) deadline? You can still file
Most investors assume they're out of luck once the date passes, but the
$7.25 million Rain Oncology settlement is currently accepting "Late-but-Valid" claims. If you bought shares between April 23, 2021 and May 19, 2023 you still have a chance to seek recovery.
Submit your late claim here: https://11th.com/cases/rain-investor-lawsuit
This recovery fund was established after claims that Rain Oncology misled investors about its lead drug candidate, milademetan, and overstated the strength and progress of its clinical trial program. Even though the official deadline has passed, the court is still accepting late submissions.